Tech giants Meta and Microsoft report strong earnings, fueling a $500 billion surge in the market value of major AI-focused companies.
Eli Lilly's diabetes drug Mounjaro demonstrates an 8% greater reduction in major adverse cardiovascular events compared to its older GLP-1 drug Trulicity in a large trial, strengthening Lilly's position in the competitive GLP-1 market.
Tech giants Meta and Microsoft report strong earnings, fueling a $500 billion surge in the market value of major AI-focused companies.
Eli Lilly's diabetes drug Mounjaro demonstrates an 8% greater reduction in major adverse cardiovascular events compared to its older GLP-1 drug Trulicity in a large trial, strengthening Lilly's position in the competitive GLP-1 market.